Abstract

MicroRNAs (miRNAs) are a class of small, well-conserved noncoding RNAs that regulate gene expression post-transcriptionally. They have been demonstrated to regulate a lot of biological pathways and cellular functions. Many miRNAs are dynamically regulated during central nervous system (CNS) development and are spatially expressed in adult brain indicating their essential roles in neural development and function. In addition, accumulating evidence strongly suggests that dysfunction of miRNAs contributes to neurological diseases. These observations, together with their gene regulation property, implicated miRNAs to be the key regulators in the complex genetic network of the CNS. In this review, we first focus on the ways through which miRNAs exert the regulatory function and how miRNAs are regulated in the CNS. We then summarize recent findings that highlight the versatile roles of miRNAs in normal CNS physiology and their association with several types of neurological diseases. Subsequently we discuss the limitations of miRNAs research based on current studies as well as the potential therapeutic applications and challenges of miRNAs in neurological disorders. We endeavor to provide an updated description of the regulatory roles of miRNAs in normal CNS functions and pathogenesis of neurological diseases.

Highlights

  • In a short highlight [73], the authors suggested that mitochondria are prime candidates for regulating miRNA activity based on two pieces of evidence, namely, thermodynamics of miRNA:mRNA interaction and the interaction between mitochondria and other cellular compartments, organelles and cytoplasmic foci is important for energy distribution, signaling and homeostasis

  • Considering the important roles of neuronal mRNA transportation, local protein synthesis and mitochondria in many events of the central nervous system (CNS) [74,75], it is worthy pointing out this highly novel dimension of gene regulation by the interaction and crosstalk between miRNA and mitochondria, and further studying how these interactions mediate responses to cellular cues in the CNS. This undiscovered mechanism in gene regulation might advance our knowledge in miRNA regulation in the CNS and bring effective means to control abnormal events happened in the CNS in future

  • These findings suggest the profound effect of miRNA on CNS inflammation and related neurological diseases

Read more

Summary

Introduction

The pri-miRNA is cleaved in the nucleus by the endoribonuclease Drosha, a member of the RNase III proteins, into ~70 nucleotide stem-loop precursor miRNA (pre-miRNA) [4]. The product, pre-miRNA, is exported to the cytoplasm with the aids of an exportin5-Ran-GTP complex and further processed by another member of RNase III protein—Dicer into ~22 base pair miRNA/miRNA* (guided strand/passenger strand of the same hairpin structure) duplex [5,6]. The steady expression level of miRNAs is regulated by both biogenesis and degradation, the latter has received limited attention so far, partially due to the long decay period of which can be ten times longer than that of mRNAs [11]. The quick decaying response of miRNAs to physiological stimuli, including illumination change and synaptic stimulation, implicates that active miRNAs metabolism might strongly support the neuronal functions and plasticity [14]

Mechanisms of miRNA Regulation
MicroRNA Regulation and Function in the Central Nervous System
MicroRNA Regulation by Mitochondria
MicroRNA Regulation by Neuronal Activity
MicroRNA Function in the CNS
MicroRNA Function in Embryonic Neural Development
MicroRNA Function in NSCs Proliferation and Differentiation
MicroRNA Function in Neuronal Migration and Integration
MicroRNA Function in Dendritic Complexity
MicroRNA Function in Axon Outgrowth and Guidance
MicroRNA Function in Synaptogenesis and Synaptic Plasticity
MicroRNA Function in CNS Inflammation
Implications of miRNAs in Neurological Diseases
Fragile X Syndrome
Rett Syndrome
Autism Spectrum Disorders
Major Depression Disorder
Schizophrenia
Alzheimer’s Disease
Parkinson’s Disease
Therapeutic Applications and Challenges
Conclusions and Outlook

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.